Published on
July 2, 2024
- 11:45 GMT
Armis Biopharma names Michael J. Voss as new CEO, replacing Ted Ziemann who is retiring
FT. COLLINS, COLORADO, UNITED STATES, July 2, 2024 /EINPresswire.com/ -- Armis Biopharma Announces the Appointment of Michael J. Voss to CEO, replacing Ted Ziemann who is Retiring July 1st. Armis Biopharma, Inc. announced today that it has appointed …
Distribution channels:
Business & Economy, Consumer Goods
...
